Literature DB >> 12700303

Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq.

A Al-Araji1, K Sharquie, Z Al-Rawi.   

Abstract

OBJECTIVES: To determine the prevalence of neurological involvement in Behcet's disease in a prospective study, and to describe the clinical patterns of neurological presentation in this disease in patients attending a multidisciplinary clinic in Baghdad.
METHODS: All patients attending the clinic who fulfilled the international study group criteria for the diagnosis of Behcet's disease were studied during a two year period starting in April 1999. Patients were assessed neurologically by a neuro-Behcetologist. All those with clinical neurological manifestations were sent for CSF examination, cranial magnetic resonance imaging, and magnetic resonance venography and were followed up to explore the patterns of neurological relapse.
RESULTS: 140 patients with Behcet's disease were studied. Their mean age was 34.2 years (range 16 to 66); 105 (75%) were men and 35 (25%) were women. The mean duration of the disease was 4.2 years (range 0.4 to 26). Twenty patients (14%) had neurological involvement (neuro-Behcet's disease); 14 of these (70%) were men and six (30%) women. The mean age at the first neurological presentation was 34.1 years. The mean duration of follow up of patients with neuro-Behcet's disease was 20.7 months. Ten patients with neuro-Behcet's disease (50%) presented with parenchymal CNS involvement, six (30%) with intracranial hypertension, and four (20%) with a mixed pattern of both parenchymal CNS involvement and intracranial hypertension.
CONCLUSIONS: Careful neurological assessment of patients with Behcet's disease may show a relatively high prevalence of neuro-Behcet features, and though the clinical patterns of presentation are characteristic a mixed pattern may occur.

Entities:  

Mesh:

Year:  2003        PMID: 12700303      PMCID: PMC1738436          DOI: 10.1136/jnnp.74.5.608

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  Neuro-Behçet's disease in Japan.

Authors:  K Ikeda; M Abe; Y Iwasaki; M Kinoshita
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

2.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

Authors:  G Akman-Demir; P Serdaroglu; B Tasçi
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

3.  Neuro-Behçet's disease.

Authors:  M G Hadfield; F Aydin; H R Lippman; W S Kubal; K M Sanders
Journal:  Clin Neuropathol       Date:  1996 Sep-Oct       Impact factor: 1.368

4.  The prevalence of Behçet's syndrome in a rural area in northern Turkey.

Authors:  S Yurdakul; I Günaydin; Y Tüzün; N Tankurt; H Pazarli; Y Ozyazgan; H Yazici
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

5.  Neurologic involvement in Behçet's syndrome. A prospective study.

Authors:  P Serdaroğlu; H Yazici; C Ozdemir; S Yurdakul; S Bahar; E Aktin
Journal:  Arch Neurol       Date:  1989-03

6.  MRI findings in neuro-behçet's disease.

Authors:  S H Lee; P H Yoon; S J Park; D I Kim
Journal:  Clin Radiol       Date:  2001-06       Impact factor: 2.350

7.  [Neurological manifestations in Behcet's disease. Forty observations in a cohort of 300 patients].

Authors:  C Ben Taarit; S Turki; H Ben Maïz
Journal:  J Mal Vasc       Date:  2002-04

8.  [Behçet's disease. 316 cases].

Authors:  S Benamour; B Zeroual; R Bennis; A Amraoui; S Bettal
Journal:  Presse Med       Date:  1990-10-06       Impact factor: 1.228

9.  Behçet's disease in Saudi Arabia.

Authors:  A N al-Dalaan; S R al Balaa; K el Ramahi; Z al-Kawi; S Bohlega; S Bahabri; M A al Janadi
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

10.  Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases.

Authors:  B Wechsler; M Vidailhet; J C Piette; M G Bousser; B Dell Isola; O Blétry; P Godeau
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

View more
  30 in total

1.  Neurological involvement in North Italian patients with Behçet disease.

Authors:  Andrea Lo Monaco; Renato La Corte; Luisa Caniatti; Massimo Borrelli; Francesco Trotta
Journal:  Rheumatol Int       Date:  2006-06-23       Impact factor: 2.631

2.  Recurrent meningitis revealing a Behçet's disease.

Authors:  Laïla Benjilali; Hicham Harmouche; Siham El Bied; Jihan Raffali; Zoubida Tazi Mezalek; Mohamed Adnaoui; Mohamed Aouni; Abdelaziz Maaouni
Journal:  Rheumatol Int       Date:  2008-07-03       Impact factor: 2.631

3.  KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease.

Authors:  Harry Petrushkin; Paul J Norman; Emma Lougee; Peter Parham; Graham R Wallace; Miles R Stanford; Farida Fortune
Journal:  J Immunol       Date:  2019-08-12       Impact factor: 5.422

Review 4.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

5.  Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet's disease.

Authors:  N Melillo; S Sangle; M R Stanford; T C Andrews; D P D'Cruz
Journal:  Clin Rheumatol       Date:  2006-10-25       Impact factor: 2.980

Review 6.  The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis.

Authors:  Aksel Siva; Sabahattin Saip
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

Review 7.  Headache in Behçet's syndrome: review of literature and NYU Behçet's syndrome center experience.

Authors:  Vijay Vishwanath; Ericka Wong; Sara C Crystal; Matthew S Robbins; Maria Filopoulos; Richard B Lipton; Yusuf Yazici; Ilya Kister
Journal:  Curr Pain Headache Rep       Date:  2014-09

8.  Rapid, complete and sustained response to corticosteroids and pulse cyclophosphamide therapy in a patient with behçet and central nervous disease.

Authors:  Concepción M Nuñez-Sotelo; Luis A Gutiérrez-Gonzalez; Martín A Rodriguez
Journal:  Maedica (Buchar)       Date:  2012-12

9.  Clinical features of Behcet's disease in Egypt.

Authors:  Manal Mohamed El Menyawi; Hala Mohamed Raslan; Amr Edrees
Journal:  Rheumatol Int       Date:  2008-10-14       Impact factor: 2.631

10.  Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study.

Authors:  Kenneth T Calamia; Floranne C Wilson; Murat Icen; Cynthia S Crowson; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  Arthritis Rheum       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.